Precigen, Inc. (PGEN) — 10-Q Filings

10-Q Filings (6)

• Precigen's Net Loss Widens to $227M Amidst Warrant, Preferred Stock Shifts — Nov 13, 2025 Risk: high
  Precigen, Inc. reported a significant increase in net loss, reaching $(227.1) million for the nine months ended September 30, 2025, compared to $(106.5) million
• Precigen Revenue Plunges 43% Amid Continued R&D Focus — Aug 12, 2025 Risk: high
  PRECIGEN, INC. reported a significant decrease in total revenue for the three months ended June 30, 2025, falling to $1.2 million from $2.1 million in the prior
• Precigen, Inc. Files Q1 2025 10-Q Report — May 14, 2025 Risk: medium
  Precigen, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported financial results for the first quarter of 2025, detailing revenues and
• Precigen, Inc. Files Q3 2024 10-Q Report — Nov 14, 2024 Risk: medium
  Precigen, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Intrexon Corp, is in the pharmaceutical preparations indu
• Precigen, Inc. Files Q2 2024 10-Q — Aug 14, 2024 Risk: medium
  Precigen, Inc. filed its 10-Q for the period ending June 30, 2024, reporting on its financial performance. The company, formerly known as Intrexon Corp, is invo
• Precigen, Inc. Files 10-Q for Q1 2024 — May 14, 2024 Risk: medium
  PRECIGEN, INC. (PGEN) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Precigen, Inc. reported its Q1 2024 financial results on May 14, 2024. The f

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX